Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bayesian approach to bioequivalence assessment: an example.

H Fluehler, A P Grieve, D Mandallaz

    Journal of Pharmaceutical Sciences
    |October 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cutaneous lymphocyte antigen and α4β7 T-lymphocyte responses are associated with peanut allergy and tolerance in children.

    Allergy·2012
    Same author

    Visible iris sign as a predictor of problems during and following anterior approach ptosis surgery.

    Eye (London, England)·2010
    Same author

    [The German version of the satisfaction with stroke care questionnaire (SASC) for stroke patients].

    Fortschritte der Neurologie-Psychiatrie·2010
    Same author

    Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register.

    Journal of neurology, neurosurgery, and psychiatry·2009
    Same author

    Black and minority ethnic men who have sex with men: a London genitourinary medicine clinic experience.

    International journal of STD & AIDS·2008
    Same author

    Discussion of the "White Paper of the PhRMA Working Group on adaptive dose-ranging designs".

    Journal of biopharmaceutical statistics·2007
    Same journal

    Green, renewable, or low-carbon? A framework for informed solvent selection in pharmaceutical sciences.

    Journal of pharmaceutical sciences·2026
    Same journal

    Theranostic potential of ramucirumab functionalized magnetoliposomes for targeted delivery of sorafenib and MRI.

    Journal of pharmaceutical sciences·2026
    Same journal

    Intranasal mucoadhesive chitosan microspheres of ranolazine: Formulation, design, and pharmacokinetic evaluation.

    Journal of pharmaceutical sciences·2026
    Same journal

    Evolving landscape of drug development for pediatric rare diseases-from successes to strategies for addressing unmet needs.

    Journal of pharmaceutical sciences·2026
    Same journal

    A mathematical framework for predicting tablet weight variability from blend particle size distribution and tooling geometry.

    Journal of pharmaceutical sciences·2026
    Same journal

    Recrystallization can stop nitrosamine formation in ranitidine hydrochloride.

    Journal of pharmaceutical sciences·2026
    See all related articles

    This study outlines Bayesian analysis for bioequivalence, calculating the probability that a new drug formulation

    Area of Science:

    • Pharmacometrics
    • Biostatistics
    • Drug Development

    Background:

    • Bioequivalence studies are crucial for generic drug approval.
    • Traditional statistical methods may not fully capture uncertainty in bioequivalence assessments.
    • Bayesian approaches offer a probabilistic framework for evaluating drug formulation equivalence.

    Purpose of the Study:

    • To present statistical methods for Bayesian analysis of bioequivalence.
    • To illustrate the calculation of posterior probabilities for the ratio of true means.
    • To provide practical tools (nomograms) for assessing bioequivalence.

    Main Methods:

    • Bayesian statistical inference applied to bioequivalence.
    • Calculation of posterior probability distributions.

    Related Experiment Videos

  • Development and use of nomograms for probability estimation.

    • Main Results:

    • The study details a method for Bayesian bioequivalence analysis.
    • Posterior probabilities can be calculated based on experimental data.
    • Nomograms are provided to aid in determining these probabilities.

    Conclusions:

    • Bayesian analysis provides a robust framework for bioequivalence assessment.
    • The presented methods and nomograms facilitate practical application.
    • This approach enhances the evaluation of drug formulation equivalence.